Detection and Identification of Tumor-Associated Protein Variants in Human Hepatocellular Carcinomas

Hepatology

Volumn 39, Issue 2, 2004, Pages 540-549

  Zeindl Eberhart, Evelyn ^a   Haraida, Sibylle ^a   Liebmann, Sibylle ^a   Jungblut, Peter Roman ^b   Lamer, Stephanie ^b   Mayer, Doris ^c   Jäger, Gundula ^d   Chung, Stephen ^e   Rabes, Hartmut Manfred ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d M V P Inst for Hyg/Med Microb   (Germany)

^e UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL DEHYDROGENASE; ALDEHYDE REDUCTASE; ALDOSE REDUCTASE LIKE PROTEIN 1; CARBONYL REDUCTASE (NADPH); PROTEOME; TUMOR MARKER; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; COLON ADENOCARCINOMA; CONTROLLED STUDY; DISEASE MARKER; ENZYMOLOGY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER; LIVER ADENOMA; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER TUMOR; MALE; MASS SPECTROMETRY; METABOLISM; NODULAR HYPERPLASIA; NUCLEOTIDE SEQUENCE; PEPTIDE MAPPING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FAMILY; PROTEIN VARIANT; PROTEOMICS; TWO DIMENSIONAL ELECTROPHORESIS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ADULT; ALCOHOL OXIDOREDUCTASES; CARCINOMA, HEPATOCELLULAR; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; PEPTIDE MAPPING; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 1242321294     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20060     Document Type: Article

References (49)

1. Henry SH, Bosch FX, Troxell TC, Bolger PM. Policy forum: public health. Reducing liver cancer-global control of aflatoxin. Science 1999;286:2453-2454.
2. Seow TK, Liang RC, Leow CK, Chung MC. Hepatocellular carcinoma: from bedside to proteomics. Proteomics 2001;10:1249-1263.
3. Marwoto W, Miskad UA, Siregar NC, Gani RA, Boedihusodo U, Nurdjanah S, Suwarso, et al. Immunohistochemical study of p53, PCNA and AFP in hepatocellular carcinoma, a comparison between Indonesian and Japanese cases. Kobe J Med Sci 2000;46:217-229.
4. Qin LX, Tang ZY. The prognostic molecular markers in hepatocellular carcinoma. World J Gastroenterol 2002;8:385-392.
5. Zeindl-Eberhart E, Klugbauer S, Dimitrijevic N, Jungblut PR, Lamer S, Rabes HM. Proteome analysis of rat hepatomas: carcinogen-dependent tumor-associated protein variants. Electrophoresis 2001;22:3009-3018.
6. Zeindl-Eberhart E, Jungblut PR, Otto A, Rabes HM. Identification of tumor-associated protein variants during rat hepatocarcinogenesis. Aldose reductase. J Biol Chem 1994;269:14589-14594.
7. Zeindl-Eberhart E, Jungblut PR, Rabes HM. Expression of tumor-associated protein variants in chemically induced rat hepatomas and transformed rat liver cell lines determined by two-dimensional gel electrophoresis. Electrophoresis 1994;15:372-381.
8. Zeindl-Eberhart E, Jungblut PR, Otto A, Kerler R, Rabes HM. Further characterization of a rat hepatoma-derived aldose-reductase-like protein. Eur J Biochem 1997;247:792-800.
9. Wirth PJ. Two-dimensional polyacrylamide gel electrophoresis in experimental hepatocarcinogenesis studies. Electrophoresis 1994;15:358-371.
10. Newsholme SJ, Maleeff BF, Steiner S, Anderson NL, Schwartz LW. Two-dimensional electrophoresis of liver proteins: characterization of a drug-induced hepatomegaly in rats. Electrophoresis 2000;21:2122-2128.
11. Wirth PJ, Hoang TN, Benjamin T. Micropreparative immobilized pH gradient two-dimensional electrophoresis in combination with protein microsequencing for the analysis of human liver proteins. Electrophoresis 1995;16:1946-1960.
12. Yu LR, Zeng R, Shao XX, Wang N, Xu YH, Xia QC. Identification of differentially expressed proteins between human hepatoma and normal liver cell lines by two-dimensional electrophoresis and liquid chromatography-ion trap mass spectrometry. Electrophoresis 2000;21:3058-3068.
13. Seow TK, Ong S-E, Liang RCMY, Ren E-C, Chan L, Ou K, Chung MCM. Two-dimensional electrophoresis map of the human hepatocellular carcinoma cell line, HCC-M, and identification of the separated proteins by mass spectrometry. Electrophoresis 2000;21:1787-1813.
14. Liang RC, Neo JC, Lo SL, Tan GS, Seow TK, Chung MC. Proteome database of hepatocellular carcinoma. J Chromatogr B Analyt Technol Biomed Life Sci 2002;771:303-328.
15. Yoon GS, Lee H, Jung Y, Yu E, Moon HB, Song K, Lee I. Nuclear matrix of calreticulin in hepatocellular carcinoma. Cancer Res 2000;60:1117-1120.
16. Park KS, Kim H, Kim NG, Cho SY, Choi KH, Seong JK, Paik YK. Proteomic analysis and molecular characterization of tissue ferritin light chain in hepatocellular carcinoma. HEPATOLOGY 2002;35:1459-1466.
17. Park KS, Cho SY, Kim H, Paik YK. Proteomic alterations of the variants of human aldehyde dehydrogenase isozymes correlate with hepatocellular carcinoma. Int J Cancer 2002;97:261-265.
18. Lim SO, Park SJ, Kim W, Park SG, Kim HJ, Kim YI, Sohn TS, et al. Proteome analysis of hepatocellular carcinoma. Biochem Biophys Res Commun 2002;291:1031-1037.
19. Le Naour F, Brichory F, Misek DE, Brechot C, Hanash SM, Beretta L. A distinct repertoire of autoandbodies in hepatocellular carcinoma identified by proteomic analysis. Mol Cell Proteomics 2002;1:197-203.
20. Cho SY, Park KS, Shim JE, Kwon MS, Joo KH, Lee WS, Chang J, et al. An integrated proteome database for two-dimensional electrophoresis data analysis and laboratory information management system. Proteomics 2002;2:1104-1113.
21. Hanash S. Disease proteomics. Nature 2003;422:226-232.
22. Jez JM, Flynn TG, Penning TM. A new nomenclature for the aldo-keto reductase superfamily. Biochem Pharmacol 1997;54:639-647.
23. Maser E. Xenobiotic carbonyl reduction and physiological steroid oxidoreduction. Biochem Pharmacol 1995;49:421-440.
24. Cao D, Tat Fans S, Chung SSM. Identification and characterization of a novel human aldose reductase-like gene. J Biol Chem 1998;273:11429-11435.
25. Scuric Z, Stain SC, Anderson WF, Hwang J-J. New member of aldose reductase family proteins overexpressed in human hepatocellular carcinoma. HEPATOLOGY 1998;27:943-950.
26. Ellis EM, Judah DJ, Neal GE, Hayes JD. An ethoxyquin-inducible aldehyde reductase from rat liver that metabolizes aflatoxin B1 defines a subfamily of aldo-keto reductases. Proc Natl Acad Sci USA 1993;90:10350-10354.
27. Praml C, Savelyeva L, Perri P, Schwab M. Cloning of the human aflatoxin B1-aldehyde reductase gene at 1p35-1p36.1 in a region frequently altered in human tumor cells. Cancer Res 1998;58:5014-5018.
28. Klose J. Fractionated extraction of total tissue proteins from mouse and human for 2-D electrophoresis. Methods Mol Biol 1999;112:67-85.
29. Klose J, Kobalz U. Two-dimensional electrophoresis of proteins: an updated protocol and implications for a functional analysis of the genome. Electrophoresis 1995;16:1034-1059.
30. Anderson NL, Anderson NG. Analytical techniques for cell fractions. XXII. Two-dimensional analysis of serum and tissue proteins: multiple gradient-slab gel electrophoresis. Anal Biochem 1978;85:341-354.
31. Anderson NG, Anderson NL. Analytical techniques for cell fractions. XXI. Two-dimensional analysis of serum and tissue proteins: multiple isoelectric focusing. Anal Biochem 1978;85:331-340.
32. Zeindl-Eberhart E, Rabes HM. Variant protein patterns in hepatomas and transformed liver cell lines as determined by high resolution two-dimensional gel electrophoresis (2DE). Carcinogenesis 1992;13:1177-1183.
33. Jungblut PR, Seifert R. Analysis by high-resolution two-dimensional electrophoresis of differentiation-dependent alterations in cytosolic protein pattern of HL-60 leukemic cells. J Biochem Biophys Methods 1990;21:47-58.
34. Lamer S, Jungblut PR. Matrix-assisted laser desorption-ionization mass spectrometry peptide mass fingerprinting for proteome analysis: identification efficiency after on-blot or in-gel digestion with and without desalting procedures. J Chromatogr B Biomed Sci Appl 2001;752:311-322.
35. Zeindl-Eberhart E, Jungblut PR, Rabes HM. A new method to assign immunodetected spots in the complex two-dimensional electrophoresis pattern. Electrophoresis 1997;18:799-801.
36. Carper DA, Wistow G, Nishimura C, Graham C, Watanabe K, Fujii Y, Hayashi O, et al. A superfamily of NADPH-dependent reductases in eukaryotes and prokaryotes. Exp Eye Res 1989;49:377-388.
37. Hyndman DJ, Flynn TG. Sequence and expression levels in human tissues of a new member of the aldo-keto reductase family. Biochim Biophys Acta 1998;1399:198-202.
38. Hyndman D, Flynn TG. The aldo-keto reductases and their role in cancer. Adv Exp Med Biol 1999;463:427-434.
39. Alaiya AA, Franzen B, Auer G, Linder S. Cancer proteomics: from identification of novel markers to creation of artificial learning models for tumor classification. Electrophoresis 2000;21:1210-1217.
40. Takahashi M, Fujii J, Miyoshi E, Hoshi A, Taniguchi N. Elevation of aldose reductase gene expression in rat primary hepatoma and hepatoma cell lines: implication in detoxification of cytotoxic aldehydes. Int J Cancer 1995;62:749-754.
41. Tsuchida S, Sato K. Glutathione transferases and cancer. Crit Rev Biochem Molec Biol 1992;27:337-384.
42. Murata M, Ohta N, Sakurai S, Alam S, Tsai J, Kador PF, Sato S. The role of aldose reductase in sugar cataract formation: aldose reductase plays a key role in lens epithelial cell death (apoptosis). Chem Biol Interact 2001;130-132:617-625.
43. Svanberg B, Ling C, Svensson PA, Johnson M, Carlsson B, Billig H. Isolation of differentially expressed aldose reductase in ovaries after estrogen withdrawal from hypophysectomized diethylstilbestrol treated rats: increased expression during apoptosis. Mol Cell Endocrinol 2000;164:183-190.
44. Bannasch P. Pathogenesis of hepatocellular carcinoma: sequential cellular, molecular, and metabolic changes. Prog Liver Dis 1996;14:161-197.
45. Jeffery J, Jörnvall H. Enzyme relationships in a sorbitol pathway that bypasses glycolysis and pentose phosphates in glucose metabolism. Proc Natl Acad Sci U S A 1983;80:901-905.
46. Stevens MJ, Henry DN, Thomas TP, Killen PD, Greene DA. Aldose reductase gene expression and osmotic dysregulation in cultured human retinal pigment epithelial cells. Am J Physiol 1993;265:E428-438.
47. O'connor T, Ireland LS, Harrison DJ, Hayes JD. Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members. Biochem J 1999;343:487-504.
48. Lee KW, Ko BC, Jiang Z, Cao D, Chung SS. Overexpression of aldose reductase in liver cancers may contribute to drug resistance. Anticancer Drugs 2001;12:129-132.
49. Lee EK, Regenold WT, Shapiro P. Inhibition of aldose reductase enhances HeLa cell sensitivity to chemotherapeutic drugs and involves activation of extracellular signal-regulated kinases. Anticancer Drugs 2002;13:859-868.